When administered therapeutically, GLP-1 receptor agonists work through several mechanisms: Enhancing insulin secretion from pancreatic beta cells in a glucose-dependent manner [1] [4] Suppressing glucagon release from alpha cells, reducing hepatic glucose output Slowing gastric emptying , which helps moderate post-meal blood glucose rises Promoting satiety through central nervous system pathways, potentially supporting weight reduction Investigational transdermal GLP-1 delivery systems typically utilise specialised technologies such as microneedles or active delivery methods rather than conventional patches, as GLP-1 molecules are large peptides that do not easily penetrate the skin barrier
NAD and GLP1: The Science Behind Synergy A pivotal study published in Endocrinology demonstrated that restoring intestinal NAD levels via supplementation improved GLP1 production and glucose metabolism in obese mouse models
Known for its ability to enhance GH levels without raising cortisol or prolactin levels, Ipamorelin supports muscle growth, fat loss, recovery, and overall wellness
Behavioral strategies addressing emotional eating, stress-triggered snacking, and food environment cues prevent rapid rebound independent of hormonal changes
Ozempic stays in your system for a while, so theres a little built-in grace period